Skip to main content
. 2017 Mar 9;4(4):246–265. doi: 10.1002/acn3.399

Figure 2.

Figure 2

CN‐105 improves functional outcomes in ischemic stroke. (A) Improvement in rotarod latency when CN‐105 is administered 30 min post reperfusion, compared to vehicle. Improvement is observed from first day post stroke and increase over the subsequent 7 days. (B) Improvement in the 4‐limb wire hanging test latency when CN‐105 is administered 30 min post reperfusion, compared to vehicle. Improvement is observed from day 2 post‐stroke and maintained till day 7. (C) No improvement of rotarod timing observed when CN‐105 is administered 2 and 3 h post reperfusion. (D) Rotarod latency at day 7 for all treatment groups. (*P < 0.05 and ***P < 0.001 by repeated measures ANOVA and *P < 0.05 by independent t‐test, and error bars represent standard error of mean).